Latest Period
Q1 2026
Security Snapshot
OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) Institutional Ownership
CUSIP: 67576A100
13F Institutional Holders and Ownership History from Q3 2014 to Q1 2026
Institutions Reporting
266
Shares (Excl. Options)
206,737,282
Price
$8.47
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Symbol
- OCUL on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 206,737,282
- Total 13F value
- $1,765,161,914
- Portfolio coverage rank
- 0.01%
- Share change
- +15,202,064
- Value change
- +$68,674,195
- Number of holders
- 266
- Shares outstanding
- 218,782,791
- SEC-reported price per share
- $9.24
- Insider filing price
- $9.24
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share is tracked under CUSIP 67576A100.
- 266 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 248 to 266 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $2,325,179,953 to $1,765,161,914.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 266 institutions filings for Q1 2026.
Security key
67576A100
Latest holder period
Q1 2026
13F holders
266
13D/G owners
6
CIK / CUSIP context first
Open Q1 2026 holders
OCUL full holder history
OCULAR THERAPEUTIX, INC SEC filings
OCULAR THERAPEUTIX, INC company facts
OCULAR THERAPEUTIX, INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 67576A100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
OCUL
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 15% | +22% | $371,574,057 | +$142,354,542 | 31,785,634 | +62% | FMR LLC | 30 Sep 2025 |
| Deep Track Capital, LP | 9.5% | +88% | $184,731,000 | +$85,196,590 | 20,850,000 | +86% | Deep Track Capital, LP | 31 Mar 2026 |
| SUMMER ROAD LLC | 5.7% | $131,657,773 | 12,134,357 | SUMMER ROAD LLC | 04 Dec 2025 | |||
| BlackRock, Inc. | 5.8% | $118,890,012 | 10,170,232 | BlackRock, Inc. | 30 Sep 2025 | |||
| Venrock Healthcare Capital Partners III, L.P. | 3.2% | -59% | $81,120,329 | -$71,516,295 | 6,862,972 | -47% | Venrock Healthcare Capital Partners III, L.P. | 31 Dec 2025 |
| Opaleye Management Inc. | 2.8% | $34,305,750 | 4,342,500 | Opaleye Management Inc. | 31 Dec 2024 |
As of 31 Mar 2026, 266 institutional investors reported holding 206,737,282 shares of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL). This represents 94% of the company’s total 218,782,791 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
75%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 15% | 32,653,764 | +2.7% | 0.01% | $276,577,378 |
| Deep Track Capital, LP | 9% | 19,686,282 | +144% | 3.4% | $166,742,809 |
| BlackRock, Inc. | 7.4% | 16,132,931 | +3.4% | 0% | $136,645,927 |
| Avoro Capital Advisors LLC | 5.6% | 12,315,000 | +14% | 1% | $104,308,050 |
| Summer Road LLC | 5.4% | 11,879,825 | +6.9% | 71% | $100,622,118 |
| Venrock Adviser, LLC | 4.7% | 10,346,926 | +41% | 3.3% | $87,638,463 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 8,719,039 | 0% | 0% | $73,850,260 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.7% | 5,897,149 | +3338% | 0.01% | $49,950,000 |
| Point72 Asset Management, L.P. | 2.5% | 5,534,985 | +445% | 0.08% | $46,881,323 |
| STATE STREET CORP | 2.2% | 4,708,419 | +12% | 0% | $39,880,309 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.1% | 4,529,185 | +4% | 0% | $38,368,500 |
| ALLIANCEBERNSTEIN L.P. | 1.9% | 4,129,687 | -4.9% | 0.02% | $50,134,400 |
| Logos Global Management LP | 1.8% | 3,850,000 | +10% | 1.7% | $32,609,500 |
| Octagon Capital Advisors LP | 1.4% | 3,166,600 | +21% | 3% | $26,821,102 |
| Balyasny Asset Management L.P. | 1.2% | 2,692,622 | +253% | 0.04% | $22,806,508 |
| Commodore Capital LP | 1.2% | 2,575,000 | 1.3% | $21,810,250 | |
| DELTEC ASSET MANAGEMENT LLC | 1.1% | 2,340,620 | -5.9% | 3.6% | $19,825,051 |
| TWO SIGMA INVESTMENTS, LP | 0.84% | 1,830,159 | +381% | 0.01% | $15,501,447 |
| Woodline Partners LP | 0.76% | 1,667,609 | +0.09% | 0.05% | $14,124,648 |
| TCG Crossover Management, LLC | 0.75% | 1,647,752 | -71% | 0.4% | $13,956,459 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.73% | 1,594,666 | 0% | 0% | $13,506,821 |
| Invesco Ltd. | 0.7% | 1,536,779 | +72% | 0% | $13,016,517 |
| NORTHERN TRUST CORP | 0.7% | 1,525,626 | +4.3% | 0% | $12,922,052 |
| UBS Group AG | 0.7% | 1,520,631 | +22% | 0% | $12,879,744 |
| Defilade Capital Management, L.P. | 0.68% | 1,487,645 | +118% | 1.9% | $12,600,353 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
47
Latest
Q1 2026
Rows shown
1-25 of 47
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 206,737,282 | $1,765,161,914 | +$68,674,195 | $8.47 | 266 |
| 2025 Q4 | 191,554,393 | $2,325,179,953 | +$30,110,921 | $12.14 | 248 |
| 2025 Q3 | 188,183,085 | $2,200,137,136 | +$370,394,002 | $11.69 | 214 |
| 2025 Q2 | 156,434,424 | $1,451,692,801 | +$187,013,442 | $9.28 | 182 |
| 2025 Q1 | 137,366,906 | $1,007,015,604 | +$22,122,134 | $7.33 | 195 |
| 2024 Q4 | 133,836,935 | $1,142,923,387 | -$55,464,898 | $8.54 | 177 |
| 2024 Q3 | 139,959,663 | $1,219,693,896 | +$26,591,052 | $8.70 | 167 |
| 2024 Q2 | 137,374,655 | $939,612,942 | +$86,876,988 | $6.84 | 148 |
| 2024 Q1 | 123,359,441 | $1,120,804,208 | +$453,790,279 | $9.10 | 145 |
| 2023 Q4 | 73,706,225 | $328,758,787 | +$150,569,150 | $4.46 | 118 |
| 2023 Q3 | 40,429,130 | $126,952,212 | -$14,507,076 | $3.14 | 112 |
| 2023 Q2 | 43,457,924 | $224,194,712 | +$15,406,633 | $5.16 | 132 |
| 2023 Q1 | 40,293,660 | $212,326,580 | +$6,217,594 | $5.27 | 124 |
| 2022 Q4 | 39,631,821 | $111,363,550 | -$11,852,132 | $2.81 | 110 |
| 2022 Q3 | 42,784,711 | $177,641,770 | -$6,246,780 | $4.15 | 126 |
| 2022 Q2 | 44,283,851 | $178,116,533 | +$2,778,803 | $4.02 | 121 |
| 2022 Q1 | 43,481,638 | $215,332,400 | +$8,618,176 | $4.95 | 127 |
| 2021 Q4 | 41,528,139 | $289,118,916 | -$36,286,646 | $6.97 | 137 |
| 2021 Q3 | 44,501,826 | $445,218,082 | -$45,732,043 | $10.00 | 137 |
| 2021 Q2 | 48,348,304 | $685,490,035 | +$13,999,445 | $14.18 | 146 |
| 2021 Q1 | 47,154,599 | $773,686,821 | -$65,718,337 | $16.41 | 149 |
| 2020 Q4 | 50,434,472 | $1,043,919,487 | +$206,608,703 | $20.70 | 146 |
| 2020 Q3 | 39,773,072 | $302,720,116 | +$7,274,447 | $7.61 | 101 |
| 2020 Q2 | 38,676,765 | $322,007,676 | +$85,260,671 | $8.33 | 103 |
| 2020 Q1 | 28,477,673 | $140,961,353 | +$17,928,044 | $4.95 | 87 |